Location: Australia wide (position and meetings conducted online)
Remuneration: In line with the conditions and rates in the Department of Health, Disability and Ageing Renumeration Framework and the Australian Government Remuneration Tribunal (Remuneration and Allowances for Holders of Part-time Public Office) Determination 2025 for specified health professional committees.
Background: Newborn bloodspot screening (NBS) programs are delivered independently by states and territories. Following the Australian Government’s commitment in 2022 to expand and achieve consistency in NBS programs, all governments have been working in partnership to consider which conditions are screened.
The Program Management Committee: The PMC comprises technical experts including senior clinical and laboratory scientists, clinicians, NBS program managers and policy makers and may include additional experts as required.
The role of PMC clinicians: non-voting; provide condition-specific, treatment, and research advice to support PMC deliberations; act independently; monthly meetings; 2-year initial term.
Eligibility and confidentiality: Australian citizen and reside in Australia; declare conflicts of interest; confidentiality obligations.
Remuneration details: Fees for sitting time and preparation time; etc.
Further information: Appendix B; etc.
Requirements
general paediatricians
endocrinologists
geneticists
neurologists
metabolic clinicians
other clinicians with relevant experience/interest in newborn screening
Experience in the following areas is desirable, but not essential: treating/managing paediatric populations
participating in committees and/or providing independent clinical advice to inform health policy
Australian citizen and reside in Australia
evidence of qualifications and/or current registration with the Australian Health Practitioner Regulation Agency (where relevant)
2 professional referee contact details
a declaration of any real or perceived Conflicts of Interest